Literature DB >> 7809471

Quantitative cultures and drug susceptibility testing of Mycobacterium avium clinical isolates before and during the antimicrobial therapy.

L B Heifets1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7809471     DOI： 10.1016/0923-2508(94)90017-5

Source DB:  PubMed          Journal:  Res Microbiol        ISSN： 0923-2508            Impact factor:   3.992


× No keyword cloud information.
  4 in total

1.  Management of opportunist mycobacterial infections: Joint Tuberculosis Committee Guidelines 1999. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society.

Authors: 
Journal:  Thorax       Date:  2000-03       Impact factor: 9.139

Review 2.  Susceptibility testing of Mycobacterium avium complex isolates.

Authors:  L Heifets
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

3.  Antimycobacterial agents differ with respect to their bacteriostatic versus bactericidal activities in relation to time of exposure, mycobacterial growth phase, and their use in combination.

Authors:  Irma A J M Bakker-Woudenberg; Wim van Vianen; Dick van Soolingen; Henri A Verbrugh; Michiel A van Agtmael
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

4.  Nontuberculous mycobacterial infection of the musculoskeletal system in immunocompetent hosts.

Authors:  Manit K Gundavda; Hitendra G Patil; Vikas M Agashe; Rajeev Soman; Camilla Rodriques; Ramesh B Deshpande
Journal:  Indian J Orthop       Date:  2017 Mar-Apr       Impact factor: 1.251
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.